Rapamycin, Mycophenolate Mofetil, Methylprednisolone, and Cytotoxic T-Lymphocyte-Associated Antigen 4 Immunoglobulin-Based Conditioning Regimen to Induce Partial Tolerance to Hind Limb Allografts Without Cytoreductive Conditioning

Transplantation Proceedings

Volumn 40, Issue 5, 2008, Pages 1714-1721

  Pan, H ^a   Wang, L ^a   Zhang, X ^a   Zhang, G ^a   Mai, H ^a   Han, Y ^a   Guo, S ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; CYCLOSPORIN A; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN;

ACUTE GRAFT REJECTION; ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; BROWN NORWAY RAT; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; LEWIS RAT; MALE; MIXED LYMPHOCYTE CULTURE; NONHUMAN; PRIORITY JOURNAL; RAT;

ACETAMINOPHEN; ANALGESIA; ANALGESICS; ANIMALS; BUPRENORPHINE; HINDLIMB; IMMUNE TOLERANCE; IMMUNOCONJUGATES; IMMUNOSUPPRESSIVE AGENTS; MALE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; PAIN, POSTOPERATIVE; RATS; RATS, INBRED BN; RATS, INBRED LEW; SIROLIMUS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 45449100541     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.03.152     Document Type: Article

References (23)

1. Gander B., Brown C.S., Vasilic D., et al. Composite tissue allotransplantation of the hand and face: a new frontier in transplant and reconstructive surgery. Transpl Int 19 (2006) 868
2. Pidwell D.J., and Burns C. The immunology of composite tissue transplantation. Clin Plast Surg 34 (2007) 303
3. Brouha P.C.R., and Ildstad S.T. Mixed allogeneic chimerism past, present and prospects for the future. Transplantation 72 8 suppl (2001) 536
4. Fehr T., and Sykes M. Tolerance induction in clinical transplantation. Transpl Immunol 13 (2004) 117
5. Dey B., Sykes M., and Spitzer T. Outcomes of recipients of both bone marrow and solid organ transplants: a review. Medicine (Baltimore) 77 (1998) 355
6. Blaha P., Bigenzahn S., Koporc Z., et al. Short-term immunosuppression facilitates induction of mixed chimerism and tolerance after bone marrow transplantation without cytoreductive conditioning. Transplantation 80 (2005) 237
7. Lee W.P., Cina R.A., Randolph M.A., et al. In utero bone marrow transplantation induces kidney allograft tolerance across a full major histocompatibility complex barrier in swine. Transplantation 79 (2005) 1084
8. Doi K. Homotransplantation of limbs in rats. Plast Reconstr Surg 64 (1979) 613
9. Bühler L.H., Spitzer T.R., Sykes M., et al. Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease. Transplantation 74 (2002) 1405
10. Sykes M., Preffer F., McAffee S., et al. Mixed lymphohaemopoietic chimerism and graft-vs-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone marrow transplantation. Lancet 353 (1999) 1755
11. Heitger A., Blaha P., Bigenzahn S., et al. The influence of immunosuppressive drugs on cell-induced graft tolerance. Curr Opin Organ Transplant 9 (2004) 307
12. Siemionow M., Oke R., Ozer K., et al. Induction of donorspecific tolerance in rat hind-limb allografts under antilymphocyte serum and cyclosporine A protocol. J Hand Surg [Am] 27 (2002) 1095
13. Taylor P.A., Lees C.J., Wilson J.M., et al. Combined effects of calcineurin inhibitors or sirolimus with anti-CD40L mAb on alloengraftment under nonmyeloablative conditions. Blood 100 (2002) 3400
14. Ledbetter J.A., Imboden J.B., Schieven G.L., et al. CD28 ligation in T-cell activation: evidence for two signal transduction pathways. Blood 75 (1990) 1531
15. Mackey M.F., Barth Jr. R.J., and Noelle R.J. The role of CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells. J Leukoc Biol 63 (1998) 418
16. Kenyon N.S., Fernandez L.A., Lehmann R., et al. Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. Proc Natl Acad Sci 96 (1999) 8132
17. Najafian N., and Sayegh M.H. CTLA4-Ig: a novel immunosuppressive agent. Exp Opin Invest Drugs 9 (2000) 2147
18. Anam K., Akpinar E., Craighead N., et al. Targeted T-cell depletion or CD154 blockade generates mixed hemopoietic chimerism and donor-specific tolerance in mice treated with sirolimus and donor bone marrow. Transplantation 78 (2004) 1290
19. Linsley P., Brady W., Urnes M., et al. CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 174 (1991) 561
20. Monaco A.P. Prospects and strategies for clinical tolerance. Transplant Proc 36 (2004) 227
21. Calne R.Y. Prope tolerance: the future of organ transplantation from the laboratory to the clinic. Int Immunopharmacol 5 (2005) 163
22. Sachs DH: Mixed chimerism as an approach to transplantation tolerance. Clin Immunol 95:
23. Wagner J.E. Prevention of graft failure by cyclosporine in rats receiving lymphocyte-depleted MHC-mismatched bone marrow. Transplantation 53 (1992) 624